| Patient | Joe Louis |
|---|---|
| Date of birth | 1971-05-13 |
| Identifiers | MRN HR-BX002-SYN; SSN (made up) 000-02-6639 |
| Document date | 2026-07-20 |
| Author | Desmond Achterberg-Cole, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
One-week review of persecutory thoughts, seen the same day by addiction psychiatry. [S]
Mr. Louis returns one week after intake and is seen by Dr. Featherstone-Ibe of addiction psychiatry on the same day. He has used no cocaine since three days before his intake visit, ten days in all, and has kept his naloxone and test strips at home. The belief that people are following him and plan to harm him is less intense but still there; he checks the street from his window several times a night and sleeps about four hours. He has had no hallucinations and no thoughts of harming himself or anyone else, and he has not confronted anyone. The phone check three days after intake found him safe. The intake urine test, done with his consent, was positive for cocaine and negative for fentanyl, other opioids, amphetamines, benzodiazepines and cannabis. HIV, hepatitis C and syphilis tests were negative; he is not infected with hepatitis B and is not immune. His thyroid and vitamin B12 tests were normal. His brain MRI this morning showed no contusion, microbleeds or other abnormality. He wants to get well and agreed to the specialist plan. [S]
| Element | Detail |
|---|---|
| Last cocaine use | Ten days ago |
| Persecutory beliefs | Present, less intense; partial insight |
| Sleep | About four hours |
| Intake results | Urine positive for cocaine, negative for fentanyl and other drugs; HIV, hepatitis C and syphilis negative; hepatitis B not immune; TSH and B12 normal |
| Brain MRI | Normal for age |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired from short sleep; appetite normal |
| Cardiovascular | Negative | No chest pain or palpitations since the collapse |
| Neurological | Negative | No headache, weakness or numbness |
| Psychiatric | Positive | Persecutory beliefs persist; no hallucinations; no thoughts of suicide or of harming anyone |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with fentanyl test strips and instruction for him and anyone he lives with | One spray as needed for suspected overdose; repeat in 2 to 3 minutes if needed | Nasal route | 2026-07-13 | active | S |
| Aripiprazole 5 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 2026-07-20 to 2026-09-21 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-20 | Body height | 187 | cm | S |
| 2026-07-20 | Body weight | 101 | kg | S |
| 2026-07-20 | Body mass index (BMI) [Ratio] | 28.9 | kg/m2 | S |
| 2026-07-20 | Systolic blood pressure | 148 | mm[Hg] | S |
| 2026-07-20 | Diastolic blood pressure | 94 | mm[Hg] | S |
| 2026-07-20 | Heart rate | 90 | /min | S |
| 2026-07-20 | Respiratory rate | 16 | /min | S |
| 2026-07-20 | Body temperature | 36.8 | Cel | S |
| 2026-07-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-20 | Cholesterol [Mass/volume] in Serum or Plasma | 204 | mg/dL | <=199 mg/dL | High | S |
| 2026-07-20 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-07-20 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 128 | mg/dL | <=99 mg/dL | High | S |
| 2026-07-20 | Triglyceride [Mass/volume] in Serum or Plasma | 160 | mg/dL | <=149 mg/dL | High | S |
Vital signs recorded on 2026-07-20; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert; blood pressure 148/94, pulse 90; weight 101.0 kg |
| Ears, nose, mouth, and throat | Nasal septum intact |
| Neurological | Cranial nerves normal; no tremor, rigidity or abnormal movements (AIMS 0); gait normal |
| Psychiatric | Courteous and watchful; persecutory delusion held less firmly than a week ago; no hallucinations; oriented; no suicidal or homicidal ideation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Persecutory thoughts and poor sleep for about two months: a fixed belief that people are following him and plan to harm him, three to four hours of sleep a night, partial insight; cause under evaluation | resolved | confirmed | R41.89 | S — Synthetic presenting problem anchored to his documented fears of a plot against his life; resolved into the diagnosis at the consultation. Not a claim about his real symptoms. |
| Cocaine use disorder, severe (seven of eleven DSM-5-TR criteria): intranasal cocaine most days for about a year, last use three days before intake | resolved | confirmed | F14.20 | S — Synthetic modern coding at intake; superseded at the consultation by the combined code once the psychotic disorder was diagnosed. Person-first language; not a claim about his real diagnosis. |
| Cocaine use disorder, severe, with cocaine-induced psychotic disorder (persecutory delusions during heavy use, persisting ten days after the last use, with no history of psychosis off cocaine, a normal examination and no evidence of a neurocognitive disorder); psychotic symptoms resolved within four weeks on aripiprazole | active | confirmed | F14.250 | S — Synthetic modern diagnosis made at the consultation. Not a claim about his real diagnosis. |
| Raised blood pressure at intake (154/98 mmHg) three days after cocaine use, without a diagnosis of hypertension; home readings planned | active | confirmed | R03.0 | S — Synthetic presenting finding; resolved into a diagnosis of hypertension at four weeks. |
| Financial insecurity: years of tax debt from his time as a well-paid athlete, now settled, left him with no savings; irregular income from paid appearances; worry about money keeps him awake | active | confirmed | Z59.86 | S — Synthetic social need anchored to his documented tax debt. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Self-management | Cocaine use since the last visit (his own account), cravings and triggers | Every visit | Completed today | No cocaine for ten days; cravings in the evenings |
| Laboratory | Urine drug tests in contingency management, with fentanyl, and prize draws for negative results | Twice weekly for twelve weeks, then at visits | Completed today | Intake test positive for cocaine, negative for fentanyl; contingency management begins today with the first test, negative |
| Examination | Psychotic symptoms, insight and sleep | Every visit | Completed today | Persecutory beliefs less firmly held; no hallucinations; sleep about four hours |
| Medication safety | Antipsychotic safety: weight, blood pressure, akathisia (Barnes scale) and abnormal movements (AIMS) | Weight and akathisia at every visit while on treatment; AIMS at baseline and every six months | Completed today | Baseline before aripiprazole: weight 101.0 kg, BMI 28.9, blood pressure 148/94; AIMS 0; no akathisia; QTc 436 ms at intake |
| Laboratory | Fasting glucose or hemoglobin A1c and lipids on an antipsychotic | Baseline, at four months, then yearly | Completed today | Baseline fasting lipids today: total cholesterol 204, HDL 44, LDL 128, triglycerides 160 mg/dL; hemoglobin A1c 5.5% at intake |
| Examination | Cognitive screen (MoCA) | At baseline and again once he is well and off cocaine | Up to date | MoCA 25 at intake during symptoms and short sleep; repeat once he is well |
| Imaging | Brain MRI for new psychotic symptoms after age 50 | Once, at presentation | Completed today | No contusion, microbleeds or mass; brain volume normal for age |
| Examination | Blood pressure in clinic and at home | Every visit; home readings before diagnosis and after each change | Ordered | 148/94 mmHg; home readings planned before the four-week visit |
| Survey | Suicide and violence risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or of harming anyone; no firearms; 988 saved in his phone |
| Medication safety | Naloxone and fentanyl test strips on hand | Every visit | Completed today | Naloxone and test strips at home; he knows how to use them |
| Survey | Depression (PHQ-9) and anxiety (GAD-7) | At baseline and every four weeks while in treatment | Up to date | PHQ-9 8 and GAD-7 9 at intake; repeat at four weeks |
| Self-management | Cognitive behavioral therapy | Weekly | Ordered | First session booked this week |
| Self-management | Finances, social work and taxpayer services | Every visit | Ordered | Social work appointment next week |
| Self-management | Family involvement, only with his consent | Every visit | Completed today | He does not want family contacted for now; respected |
| Referral | Addiction psychiatry consultation | At the start of treatment | Completed today | Seen by Dr. Featherstone-Ibe today |
Goal progress:
Guideline basis: The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2023); The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (2020); Treatment for Stimulant Use Disorders (Treatment Improvement Protocol 33, updated 2021) (2021); National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (2021); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026)
Follow-up: Four-week review in three weeks with home blood pressure readings, the PHQ-9 and GAD-7. Contingency management twice weekly and therapy weekly. Call the clinic or 988, or go to the emergency department, for any of the urgent signs on his plan. Next scheduled visit 2026-08-10: four-week review: psychotic symptoms, urine tests, blood pressure and a diagnosis of hypertension. [S]